OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 4

Data from combined, up to 2021-03-20.

Vaccinated at 2021-03-20 (%) Vaccinated at 2021-03-20 (n) Population Vaccinated at 2021-03-13 (%) Vaccinated in past week (%)
Overall - 55.6% 2,604,868 4,688,159 54.9% 0.7%
Sex Female 55.0% 1,386,721 2,522,296 54.2% 0.8%
Male 56.2% 1,218,147 2,165,863 55.6% 0.6%
Ethnicity White - British 58.9% 1,507,471 2,560,943 58.4% 0.4%
White - Irish 52.3% 14,707 28,105 51.8% 0.5%
White - Any other White background 42.7% 62,328 146,013 41.8% 0.9%
Mixed - White and Black Caribbean 38.1% 4,501 11,816 36.4% 1.7%
Mixed - White and Black African 39.1% 4,746 12,152 37.2% 1.9%
Mixed - White and Asian 46.0% 3,514 7,637 44.4% 1.6%
Mixed - Any other mixed background 41.4% 6,391 15,435 40.0% 1.4%
Asian or Asian British - Indian 49.2% 59,976 121,863 47.8% 1.4%
Asian or Asian British - Pakistani 43.7% 42,728 97,825 40.9% 2.7%
Asian or Asian British - Bangladeshi 52.9% 26,250 49,637 49.7% 3.2%
Asian or Asian British - Any other Asian background 45.3% 29,211 64,449 43.7% 1.7%
Black or Black British - Caribbean 35.7% 15,309 42,861 33.9% 1.8%
Black or Black British - African 37.4% 38,787 103,824 35.0% 2.4%
Black or Black British - Any other Black background 35.2% 6,636 18,858 33.1% 2.0%
Other ethnic groups - Chinese 46.0% 6,412 13,944 44.9% 1.1%
Other ethnic groups - Any other ethnic group 41.3% 16,156 39,130 39.9% 1.4%
Patients with any other ethnicity code 56.4% 350,007 620,886 55.8% 0.6%
Ethnicity not stated 56.1% 15,974 28,469 55.4% 0.7%
Ethnicity not recorded 55.9% 393,645 704,235 55.4% 0.5%
Ethnicity (broad categories) White 57.9% 1,584,520 2,735,089 57.5% 0.5%
Mixed 40.7% 19,166 47,054 39.1% 1.6%
South Asian 47.4% 158,179 333,781 45.3% 2.1%
Black 36.7% 60,746 165,550 34.5% 2.2%
Other 42.5% 22,582 53,074 41.2% 1.4%
Unknown 56.1% 759,640 1,353,590 55.6% 0.6%
Index of Multiple Deprivation 1 (most deprived) 50.9% 503,468 989,009 49.6% 1.3%
2 53.3% 503,839 945,434 52.4% 0.9%
3 56.6% 527,807 932,799 56.1% 0.5%
4 58.1% 524,097 901,880 57.7% 0.4%
5 (least deprived) 59.6% 521,969 876,400 59.3% 0.3%
Unknown 55.5% 23,653 42,623 55.1% 0.4%
Clinical Risk Groups Patients in Any Clinical Risk Group 54.7% 1,645,889 3,007,214 53.8% 0.9%
Patients with Immunosuppression 54.4% 235,991 434,154 53.8% 0.6%
Patients with CKD 57.8% 237,944 411,642 57.4% 0.4%
Patients who have Chronic Respiratory Disease 58.0% 341,845 589,015 57.6% 0.5%
Patients with Diabetes 51.8% 708,155 1,366,274 50.4% 1.5%
Patients with Chronic Liver disease 55.2% 116,921 211,974 54.3% 0.9%
Patients with CNS Disease (including Stroke/TIA) 58.1% 239,638 412,664 57.5% 0.6%
Patients with Chronic heart disease 58.5% 547,652 936,194 58.0% 0.5%
Patients with Asplenia or Dysfunction of the Spleen 51.5% 42,672 82,824 51.0% 0.5%
Patients with Wider Learning Disability 54.5% 30,625 56,182 53.2% 1.3%
Patients with Severe Mental Health 52.6% 41,111 78,127 51.0% 1.7%
Other Groups Patients who are shielding (High Risk from COVID-19) 51.2% 1,168,552 2,280,565 50.0% 1.2%
Patients with Morbid Obesity 53.5% 178,353 333,473 52.2% 1.3%
Patients who are pregnant 23.5% 6,664 28,350 21.4% 2.1%